INT4658
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Mu opioid receptor (MOR) is the main site of interaction for major clinical analgesics, particularly morphine. | |||||||||||||||
| |||||||||||||||
|
Mu opioid receptor (MOR) is the main site of interaction for major clinical analgesics, particularly morphine. | |||||||||||||||
| |||||||||||||||
|
These data suggest that MOR ligands, such as naloxone, can cross the plasma membrane and MOR1K is a functional intracellular receptor that binds MOR ligands. | |||||||||||||||
| |||||||||||||||
|
As intracellular localization of several receptor systems does not prevent receptor-mediated signalling [34,35], we examined whether the intracellulary localized MOR1K binds MOR ligands using flow cytometry [36] to measure binding of fluorescently labeled naloxone (Fig.1D-E). | |||||||||||||||
| |||||||||||||||
|
OBJECTIVE: 11C-carfentanil is a radiopharmaceutical that selectively binds the mu-opiate receptor of the central nervous system. | |||||||||||||||
| |||||||||||||||
|
We found, however, that opiate receptor binding is high in the fetal and infant inferior olive, in comparison to low binding reported in this site in adult humans, primates, and rodents. | |||||||||||||||
| |||||||||||||||
|
Sufentanil is the most potent of the opioids currently available for use in man, it has a very high binding affinity for the mu-opioid receptor. | |||||||||||||||
| |||||||||||||||
|
The relative potency of the analgesic effect is related to the characteristics of the opiate receptor interaction (KD, Ki). | |||||||||||||||
| |||||||||||||||
|
The failure of naloxone to inhibit morphine-induced histamine release suggests that histamine release by morphine is not dependent on opiate receptor binding or activation. | |||||||||||||||
| |||||||||||||||
|
To better understand structural requirements for a mu ligand of the trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class to interact with the mu opioid receptor, we have described in the previous article (Le Bourdonnec, B. et al. | |||||||||||||||
| |||||||||||||||
|
In this study the authors examined age- and gender-associated variations in mu-opioid receptor binding with positron emission tomography (PET). | |||||||||||||||
| |||||||||||||||
|
Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. | |||||||||||||||
| |||||||||||||||
|
In this study we examined mu opioid receptor binding in ten cocaine-dependent men and seven nonaddicted controls using positron emission tomography and [11C] carfentanil. | |||||||||||||||
| |||||||||||||||
|
The upregulation of mu opioid receptor binding persisted after 4 weeks of monitored cocaine abstinence. | |||||||||||||||
| |||||||||||||||
|
We found that a clinically used TP extract bound to the mu-opiate receptor with a high affinity (K(i)=9.7+/-1.6microg/ml). | |||||||||||||||
| |||||||||||||||
|
Peptoid trimer CHIR 2279 binds to the alpha 1-adrenergic receptor with a Ki of 5 nM, and trimer CHIR 4531 binds to the mu-opiate receptor with a Ki of 6 nM. | |||||||||||||||
| |||||||||||||||
|
Naloxonazine binds irreversibly to the mu 1-opioid receptor subtype and reversibly to the mu 2-opioid receptor subtype. | |||||||||||||||
| |||||||||||||||
|
Interaction of the mu-opioid receptor (MOP) with selected ligands was investigated in live cells using advanced imaging by confocal laser scanning microscopy integrated with fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. | |||||||||||||||
| |||||||||||||||
|
Interaction of the mu-opioid receptor (MOP) with selected ligands was investigated in live cells using advanced imaging by confocal laser scanning microscopy integrated with fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. | |||||||||||||||
| |||||||||||||||
|
In the nervous system, the interaction of opioids like heroin and morphine with the G protein-coupled Mu-opioid receptor (MOR) provokes the development of tolerance to these opioids, as well as physical dependence. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.